TOG Review (RCOG Journal)
MRCOG Part 2
Postpartum Problems (Maternal)
Postpartum contraception
Key Statistics
- 3–4 wks — Earliest ovulation post-delivery (non-breastfeeding)
- 1/3 — Term pregnancies unintended at conception
- 21 days — Hormonal method effective immediately if started ≤this
Don't-miss facts
-
LAM 98% effective only if: <6 months postpartum + exclusively breastfeeding + fully amenorrhoeic – all three required
-
CHC contraindicated (UKMEC 4) in breastfeeding women <6 weeks postpartum; delay to 3 weeks (no VTE risk factors) or 6 weeks (with risk factors) if not breastfeeding
-
PPIUC insertion window: within 48 hours of birth (post-placental from 10 min); if missed, delay interval insertion to ≥4 weeks
-
PPIUC exclusions: intrapartum/postpartum sepsis, prolonged ROM, unresolved PPH, active PID, unexplained bleeding, abnormal uterine anatomy
-
Expulsion: intra-caesarean 0–17%; vaginal PPIUC 10–34% – follow-up at 4–6 weeks to confirm position (up to 50% non- visible threads after caesarean insertion)
-
Hormonal contraception started ≤21 days postpartum = immediately effective; later start needs 7 days cover (CHC/implant/DMPA/LNG-IUS) or 2 days (POP)
-
EC not required before 21 days postpartum; Cu-IUD most effective EC (1:1000 failure), window 120 hrs; double levonorgestrel dose if BMI >35
-
Ulipristal acetate + breastfeeding: express and discard milk for 1 week after use
Method effectiveness (typical use)
Implant 0.05% · LNG-IUS 0.2% · Cu-IUD 0.8% No method 85% · FAM 24% · Condom 18%
Abbreviation Key
- LARC — long-acting reversible contraceptive
- CHC — combined hormonal contraception
- UKMEC — UK Medical Eligibility Criteria for Contraceptive Use
- VTE — venous thromboembolism
- LAM — lactational amenorrhoea method
- EC — emergency contraception
- LNG-IUS — levonorgestrel-releasing intrauterine system
- UPSI — unprotected sexual intercourse
- Cu-IUD — copper intrauterine device
- FSRH — Faculty of Sexual and Reproductive Healthcare
- PPIUC — postpartum intrauterine contraception
- RCOG — Royal College of Obstetricians and Gynaecologists
- DMPA — depot medroxyprogesterone acetate
- BMI — body mass index
- POP — progestogen-only pill
- NICE — National Institute for Health and Care Excellence
Source: Cooper M, Cameron S. Postpartum Contraception. The Obstetrician & Gynaecologist 2018;20:159–166. doi:10.1111/tog.12494
MRCOG AI is an independent educational tool. It is not affiliated with, endorsed by, or connected to the Royal College of Obstetricians and Gynaecologists (RCOG).